GSTM1 and anemia: In the ED evaluation, higher WBC (>10 × 109/L) was found in 148 patients (48.5%, 148/305), anemia (Hb <120 g/dl) in 20.7% (63/305), and higher PCT (>0.25 μg/ml) in 41.6% patients (79/190).